Viewing Study NCT00916669


Ignite Creation Date: 2025-12-24 @ 11:11 PM
Ignite Modification Date: 2025-12-25 @ 8:45 PM
Study NCT ID: NCT00916669
Status: WITHDRAWN
Last Update Posted: 2013-05-08
First Post: 2009-06-05
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Randomized Study to Evaluate the Effect of Two Different Doses of Enoxaparin Sodium in Combination With Standard Chemotherapy in Patients With Stage Small Cell Lung Cancer (SCLC)
Sponsor: Massachusetts General Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module